Please assess the completion status of the following clinical trial:

Trial Title: PAIR Study-PAP And IOP Relationship: Study 1

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Age \>40 years~* Able to give informed consent and attend for the study visit.~Exclusion Criteria:~* Previous surgical treatment for glaucoma~* Current or recent (within 4 weeks) CPAP or non-invasive ventilation (NIV) use~* History of face mask intolerance~* Any facial lesion preventing safe CPAP mask application~* Allergy to silicone~* Any contraindications to rebound tonometry, including: corneal scarring, microphthalmos, buphthalmos, nystagmus, keratoconus, abnormal central corneal thickness, corneal ectasia, active corneal infection, , and corneal dystrophies.~* Concomitant eye diseases known to affect IOP, including: treated wet age related macular degeneration (ARMD), central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), uveitis and diabetic retinopathy.~* Significant lung disease (including previous pneumothorax, previous or current respiratory failure, severe Chronic Obstructive Pulmonary Disease (COPD), bullous lung disease, difficult to control asthma, acute chest infection)~* Significant heart disease (including heart failure, unstable arrhythmias, pulmonary hypertension)~* Untreated upper gastro-intestinal obstruction~* Acute infectious diseases~* Known or suspected pregnancy

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Treated glaucoma (Type: EXPERIMENTAL): POAG patients established on treatment
- Untreated (Type: EXPERIMENTAL): Newly diagnosed treatment naïve POAG patients
- Control (Type: ACTIVE_COMPARATOR): Control subjects without glaucoma

Based on this trial design, predict the completion outcome and termination type (if applicable).